Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Artery Disease | 40 | 2024 | 6505 | 3.520 |
Why?
|
Coronary Angiography | 32 | 2024 | 4506 | 2.700 |
Why?
|
Plaque, Atherosclerotic | 13 | 2024 | 1535 | 2.280 |
Why?
|
Chest Pain | 10 | 2023 | 1097 | 1.310 |
Why?
|
Coronary Vessels | 9 | 2023 | 3111 | 1.180 |
Why?
|
Aortic Valve Stenosis | 11 | 2024 | 2018 | 1.040 |
Why?
|
Heart Valve Prosthesis Implantation | 10 | 2022 | 1555 | 0.820 |
Why?
|
Tomography, X-Ray Computed | 20 | 2024 | 20588 | 0.760 |
Why?
|
Predictive Value of Tests | 26 | 2024 | 15308 | 0.750 |
Why?
|
Cardiac Volume | 2 | 2021 | 197 | 0.730 |
Why?
|
Cardiac-Gated Imaging Techniques | 9 | 2019 | 139 | 0.730 |
Why?
|
Aortic Valve | 8 | 2015 | 1959 | 0.720 |
Why?
|
Asymptomatic Diseases | 3 | 2021 | 588 | 0.660 |
Why?
|
Mediastinitis | 1 | 2019 | 49 | 0.640 |
Why?
|
Psoas Muscles | 1 | 2018 | 66 | 0.590 |
Why?
|
Sternotomy | 1 | 2019 | 128 | 0.590 |
Why?
|
HIV Infections | 10 | 2024 | 17347 | 0.560 |
Why?
|
Fractional Flow Reserve, Myocardial | 5 | 2024 | 345 | 0.560 |
Why?
|
Atherosclerosis | 5 | 2023 | 3406 | 0.530 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 5 | 2023 | 1221 | 0.530 |
Why?
|
Pericardium | 1 | 2020 | 674 | 0.510 |
Why?
|
Calcinosis | 3 | 2023 | 1477 | 0.500 |
Why?
|
Calcium | 6 | 2023 | 5719 | 0.490 |
Why?
|
Subcutaneous Fat | 1 | 2018 | 393 | 0.470 |
Why?
|
Heart Valve Prosthesis | 5 | 2020 | 1463 | 0.470 |
Why?
|
Coronary Stenosis | 5 | 2024 | 802 | 0.430 |
Why?
|
Radiology Information Systems | 1 | 2017 | 529 | 0.420 |
Why?
|
Intra-Abdominal Fat | 1 | 2018 | 612 | 0.420 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2024 | 3245 | 0.410 |
Why?
|
Surgical Wound Infection | 1 | 2019 | 1530 | 0.330 |
Why?
|
Pulmonary Embolism | 1 | 2023 | 2571 | 0.330 |
Why?
|
Male | 58 | 2024 | 360693 | 0.320 |
Why?
|
Anti-Retroviral Agents | 1 | 2018 | 1784 | 0.310 |
Why?
|
Decision Support Systems, Clinical | 1 | 2017 | 1172 | 0.300 |
Why?
|
Middle Aged | 43 | 2024 | 220853 | 0.300 |
Why?
|
Risk Assessment | 16 | 2024 | 24021 | 0.300 |
Why?
|
Cardiovascular Diseases | 9 | 2024 | 15520 | 0.290 |
Why?
|
Risk Factors | 21 | 2024 | 74239 | 0.290 |
Why?
|
Mitral Valve Insufficiency | 3 | 2022 | 1400 | 0.290 |
Why?
|
Female | 52 | 2024 | 392544 | 0.270 |
Why?
|
Catheter Ablation | 4 | 2022 | 2751 | 0.270 |
Why?
|
Adipose Tissue | 4 | 2023 | 3313 | 0.270 |
Why?
|
Cardiac Surgical Procedures | 2 | 2019 | 3627 | 0.270 |
Why?
|
Heart Transplantation | 1 | 2020 | 3258 | 0.260 |
Why?
|
Humans | 75 | 2024 | 761208 | 0.260 |
Why?
|
Postoperative Complications | 3 | 2020 | 15637 | 0.250 |
Why?
|
Prosthesis Design | 7 | 2020 | 2114 | 0.240 |
Why?
|
Aged | 32 | 2024 | 169288 | 0.240 |
Why?
|
Sex Factors | 1 | 2018 | 10553 | 0.230 |
Why?
|
Mitral Valve | 4 | 2022 | 1465 | 0.230 |
Why?
|
Prospective Studies | 17 | 2024 | 54435 | 0.230 |
Why?
|
Germany | 3 | 2015 | 872 | 0.220 |
Why?
|
Prognosis | 10 | 2024 | 29687 | 0.210 |
Why?
|
Electrocardiography | 9 | 2019 | 6387 | 0.210 |
Why?
|
Lipoproteins, HDL | 2 | 2024 | 675 | 0.200 |
Why?
|
Endoleak | 2 | 2013 | 111 | 0.200 |
Why?
|
HIV | 3 | 2023 | 1581 | 0.200 |
Why?
|
Aged, 80 and over | 16 | 2024 | 58952 | 0.200 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2023 | 8998 | 0.190 |
Why?
|
Quinolines | 2 | 2024 | 764 | 0.190 |
Why?
|
Aortography | 2 | 2014 | 421 | 0.190 |
Why?
|
Radiography, Interventional | 3 | 2013 | 1122 | 0.190 |
Why?
|
Reproducibility of Results | 13 | 2024 | 20119 | 0.190 |
Why?
|
High-Density Lipoproteins, Pre-beta | 1 | 2020 | 6 | 0.190 |
Why?
|
Bradycardia | 1 | 2022 | 298 | 0.180 |
Why?
|
Echocardiography, Transesophageal | 2 | 2017 | 1086 | 0.170 |
Why?
|
Lipoprotein(a) | 1 | 2024 | 482 | 0.170 |
Why?
|
Contrast Media | 5 | 2023 | 5311 | 0.170 |
Why?
|
Prevalence | 4 | 2019 | 15721 | 0.160 |
Why?
|
Perfusion | 1 | 2023 | 1390 | 0.150 |
Why?
|
Nitroglycerin | 1 | 2019 | 330 | 0.150 |
Why?
|
Plasma | 1 | 2020 | 586 | 0.140 |
Why?
|
Obesity | 2 | 2023 | 12939 | 0.140 |
Why?
|
Myocardial Revascularization | 1 | 2020 | 794 | 0.140 |
Why?
|
Cytomegalovirus Infections | 1 | 2023 | 828 | 0.130 |
Why?
|
Heart Ventricles | 2 | 2020 | 3813 | 0.130 |
Why?
|
Time Factors | 5 | 2019 | 39957 | 0.130 |
Why?
|
Atrial Function, Right | 1 | 2015 | 32 | 0.130 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2020 | 395 | 0.130 |
Why?
|
Heart Function Tests | 1 | 2016 | 318 | 0.130 |
Why?
|
North America | 1 | 2019 | 1284 | 0.120 |
Why?
|
Registries | 3 | 2022 | 8247 | 0.120 |
Why?
|
Heart Injuries | 1 | 2017 | 206 | 0.120 |
Why?
|
Adiposity | 3 | 2023 | 1879 | 0.120 |
Why?
|
Pulmonary Veins | 1 | 2021 | 743 | 0.120 |
Why?
|
Vasodilation | 1 | 2019 | 966 | 0.120 |
Why?
|
Cardiovascular System | 1 | 2022 | 836 | 0.120 |
Why?
|
Early Diagnosis | 1 | 2020 | 1186 | 0.120 |
Why?
|
Retrospective Studies | 15 | 2024 | 80674 | 0.120 |
Why?
|
Vasodilator Agents | 1 | 2019 | 989 | 0.120 |
Why?
|
Observer Variation | 3 | 2017 | 2610 | 0.120 |
Why?
|
Fever | 1 | 2022 | 1618 | 0.120 |
Why?
|
Esophagus | 1 | 2020 | 1036 | 0.110 |
Why?
|
Cardiac Imaging Techniques | 1 | 2016 | 278 | 0.110 |
Why?
|
Comparative Effectiveness Research | 1 | 2019 | 709 | 0.110 |
Why?
|
Fluoroscopy | 2 | 2015 | 947 | 0.110 |
Why?
|
Vascular System Injuries | 1 | 2017 | 246 | 0.110 |
Why?
|
Heart Atria | 2 | 2020 | 1349 | 0.110 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2015 | 187 | 0.110 |
Why?
|
Tachycardia, Ventricular | 1 | 2022 | 1305 | 0.110 |
Why?
|
Atrial Flutter | 1 | 2015 | 252 | 0.110 |
Why?
|
Workflow | 2 | 2015 | 850 | 0.110 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2014 | 352 | 0.110 |
Why?
|
Aortic Aneurysm, Abdominal | 2 | 2013 | 1228 | 0.100 |
Why?
|
Exercise Test | 1 | 2020 | 2165 | 0.100 |
Why?
|
Iopamidol | 1 | 2013 | 186 | 0.100 |
Why?
|
Automation | 1 | 2015 | 585 | 0.100 |
Why?
|
Myocardial Infarction | 3 | 2023 | 11476 | 0.100 |
Why?
|
Brain Injuries | 1 | 2024 | 2054 | 0.100 |
Why?
|
Imaging, Three-Dimensional | 3 | 2014 | 4052 | 0.100 |
Why?
|
Atrial Fibrillation | 2 | 2021 | 5114 | 0.100 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2017 | 607 | 0.100 |
Why?
|
Treatment Outcome | 10 | 2022 | 64681 | 0.100 |
Why?
|
Body Burden | 1 | 2011 | 158 | 0.090 |
Why?
|
ROC Curve | 1 | 2019 | 3584 | 0.090 |
Why?
|
Cardiology | 1 | 2022 | 1693 | 0.090 |
Why?
|
Software | 2 | 2015 | 4431 | 0.090 |
Why?
|
Severity of Illness Index | 6 | 2024 | 15841 | 0.090 |
Why?
|
Preoperative Care | 3 | 2013 | 2241 | 0.090 |
Why?
|
Inflammation | 3 | 2024 | 10759 | 0.080 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39126 | 0.080 |
Why?
|
Lipoproteins, LDL | 2 | 2024 | 643 | 0.080 |
Why?
|
Catheters | 2 | 2022 | 426 | 0.080 |
Why?
|
Iohexol | 2 | 2023 | 205 | 0.080 |
Why?
|
Databases, Factual | 1 | 2024 | 7966 | 0.080 |
Why?
|
Coronary Disease | 2 | 2014 | 5921 | 0.080 |
Why?
|
Ventricular Function, Left | 2 | 2019 | 3899 | 0.070 |
Why?
|
Angiography | 1 | 2013 | 1597 | 0.070 |
Why?
|
Hemodynamics | 3 | 2022 | 4165 | 0.070 |
Why?
|
Heart Diseases | 1 | 2019 | 2795 | 0.070 |
Why?
|
Radiometry | 1 | 2011 | 812 | 0.070 |
Why?
|
Surgery, Computer-Assisted | 1 | 2013 | 1003 | 0.060 |
Why?
|
Acute Coronary Syndrome | 1 | 2018 | 2194 | 0.060 |
Why?
|
Incidence | 3 | 2024 | 21365 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36415 | 0.060 |
Why?
|
Boston | 1 | 2018 | 9327 | 0.060 |
Why?
|
Adult | 11 | 2021 | 221119 | 0.060 |
Why?
|
Health Status | 1 | 2018 | 4077 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2015 | 3366 | 0.060 |
Why?
|
Prosthesis Fitting | 2 | 2013 | 75 | 0.050 |
Why?
|
Stroke Volume | 1 | 2017 | 5521 | 0.050 |
Why?
|
Heart Rate | 2 | 2011 | 4197 | 0.050 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2023 | 127 | 0.050 |
Why?
|
Apolipoprotein A-I | 1 | 2024 | 299 | 0.050 |
Why?
|
Macrophages | 1 | 2017 | 5753 | 0.050 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2012 | 1425 | 0.050 |
Why?
|
United States | 5 | 2023 | 72339 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 1 | 2011 | 2247 | 0.050 |
Why?
|
Sensitivity and Specificity | 4 | 2024 | 14675 | 0.050 |
Why?
|
Endocardium | 1 | 2022 | 248 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2017 | 6585 | 0.050 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2023 | 269 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2024 | 1097 | 0.040 |
Why?
|
Body Mass Index | 1 | 2018 | 12952 | 0.040 |
Why?
|
Thorax | 1 | 2023 | 555 | 0.040 |
Why?
|
Administration, Sublingual | 1 | 2019 | 59 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2024 | 12341 | 0.040 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2020 | 275 | 0.040 |
Why?
|
Clinical Competence | 1 | 2015 | 4788 | 0.040 |
Why?
|
Transdermal Patch | 1 | 2019 | 51 | 0.040 |
Why?
|
Tablets | 1 | 2019 | 148 | 0.040 |
Why?
|
Eligibility Determination | 1 | 2022 | 420 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13385 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 7865 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2023 | 750 | 0.040 |
Why?
|
Esophagoscopy | 1 | 2020 | 398 | 0.040 |
Why?
|
Endovascular Procedures | 1 | 2012 | 2181 | 0.040 |
Why?
|
Linear Models | 3 | 2012 | 5869 | 0.040 |
Why?
|
Infant, Premature, Diseases | 1 | 2024 | 710 | 0.040 |
Why?
|
Lipoproteins | 1 | 2022 | 877 | 0.040 |
Why?
|
Arteries | 1 | 2022 | 1121 | 0.040 |
Why?
|
American Heart Association | 1 | 2022 | 1043 | 0.040 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 2017 | 67 | 0.040 |
Why?
|
Markov Chains | 1 | 2020 | 965 | 0.040 |
Why?
|
Mannans | 1 | 2017 | 58 | 0.030 |
Why?
|
Administration, Cutaneous | 1 | 2019 | 713 | 0.030 |
Why?
|
Mannose-Binding Lectins | 1 | 2017 | 96 | 0.030 |
Why?
|
Primary Prevention | 1 | 2024 | 1185 | 0.030 |
Why?
|
Aerosols | 1 | 2019 | 635 | 0.030 |
Why?
|
Cicatrix | 1 | 2022 | 793 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2020 | 2217 | 0.030 |
Why?
|
Quality of Life | 3 | 2022 | 13367 | 0.030 |
Why?
|
Gadolinium | 1 | 2020 | 961 | 0.030 |
Why?
|
Exercise Tolerance | 1 | 2020 | 838 | 0.030 |
Why?
|
Dextrans | 1 | 2017 | 574 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2024 | 2380 | 0.030 |
Why?
|
Gestational Age | 1 | 2024 | 3580 | 0.030 |
Why?
|
Young Adult | 2 | 2018 | 59221 | 0.030 |
Why?
|
Cohort Studies | 3 | 2022 | 41496 | 0.030 |
Why?
|
Time and Motion Studies | 1 | 2014 | 143 | 0.030 |
Why?
|
Deep Sedation | 1 | 2015 | 118 | 0.030 |
Why?
|
Infant, Premature | 1 | 2024 | 2106 | 0.030 |
Why?
|
Temperature | 1 | 2021 | 2219 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2017 | 5250 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 2017 | 539 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2017 | 585 | 0.030 |
Why?
|
Decision Support Techniques | 1 | 2024 | 2004 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2024 | 2756 | 0.030 |
Why?
|
Radiation Dosage | 2 | 2012 | 1962 | 0.030 |
Why?
|
Sinus of Valsalva | 1 | 2013 | 60 | 0.030 |
Why?
|
Coronary Circulation | 1 | 2019 | 1611 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 1039 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2019 | 1504 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2023 | 22174 | 0.030 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2015 | 507 | 0.030 |
Why?
|
Minority Groups | 1 | 2019 | 1201 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2023 | 2640 | 0.030 |
Why?
|
Iliac Artery | 1 | 2013 | 343 | 0.020 |
Why?
|
Angioplasty | 1 | 2014 | 356 | 0.020 |
Why?
|
Patient Selection | 2 | 2013 | 4246 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2023 | 8519 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4537 | 0.020 |
Why?
|
Aorta, Abdominal | 1 | 2013 | 625 | 0.020 |
Why?
|
Therapy, Computer-Assisted | 1 | 2012 | 265 | 0.020 |
Why?
|
Adolescent | 1 | 2018 | 88298 | 0.020 |
Why?
|
Propofol | 1 | 2015 | 602 | 0.020 |
Why?
|
Femoral Artery | 1 | 2013 | 826 | 0.020 |
Why?
|
Aorta | 1 | 2017 | 2040 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3840 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2019 | 2220 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 26071 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2020 | 3571 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2017 | 2024 | 0.020 |
Why?
|
Radiographic Image Enhancement | 1 | 2013 | 877 | 0.020 |
Why?
|
Patient Care Planning | 1 | 2013 | 901 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2017 | 2802 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5493 | 0.020 |
Why?
|
Hypnotics and Sedatives | 1 | 2015 | 1178 | 0.020 |
Why?
|
Regression Analysis | 1 | 2017 | 6345 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3510 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2683 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2022 | 12976 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 2013 | 1164 | 0.020 |
Why?
|
Models, Cardiovascular | 1 | 2011 | 983 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 2012 | 1096 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3418 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2017 | 3461 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2011 | 2928 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3691 | 0.010 |
Why?
|
Phenotype | 1 | 2022 | 16575 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2024 | 26199 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 2011 | 2513 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10218 | 0.010 |
Why?
|
Computer Simulation | 1 | 2011 | 6224 | 0.010 |
Why?
|
Algorithms | 1 | 2015 | 14025 | 0.010 |
Why?
|
Animals | 1 | 2024 | 168079 | 0.010 |
Why?
|